Omega Laboratories
In the Sep 2025 quarter, revenue rose 15.6% year on year to ₹22.29 Cr and net profit was ₹2.94 Cr, against ₹1.50 Cr a year earlier (compared with Sep 2024). Promoters held 69.43% of Omega Laboratories in Jan 2026, up 0.66 percentage points from Dec 2025.
Peer Comparison
Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
| ₹1,763.60 | 34.99 | 4,23,147 Cr | 5.06 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,678.50 | 87.84 | 2,56,934 Cr | 15.33 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,588.30 | 72.03 | 1,74,524 Cr | 9.50 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,195.10 | 108.45 | 1,18,604 Cr | 22.38 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,183.20 | 26.33 | 1,18,025 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,338.80 | 34.67 | 1,11,747 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,365.20 | 32.71 | 1,10,289 Cr | 3.12 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
Omega Laboratories (this company) | — | — | — | — | — | — | — | 57 Cr | 5 Cr |
| Median 8 companies | ₹1,763.60 | 34.99 | 1,18,604 Cr | 5.06 | 0.61% | 13.79% | 17.94% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
change over 1 year
Quarterly Results
| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.66 | 30.03 | 7.09 | 49.63 | 8.11 | 49.71 | 19.28 | 48.78 | 22.29 |
| Expenses | 4.41 | 28.46 | 6.63 | 47.75 | 7.2 | 46.7 | 16.44 | 46.51 | 20.41 |
| Operating Profit | 0.25 | 1.57 | 0.46 | 1.88 | 0.91 | 3.01 | 2.84 | 2.27 | 1.88 |
| OPM % | 5.36% | 5.23% | 6.49% | 3.79% | 11.22% | 6.06% | 14.73% | 4.65% | 8.43% |
| Other Income | 0 | 0.05 | 0.05 | 0.04 | 0 | 0.07 | 0.03 | 0.08 | 2.58 |
| Interest | 0.05 | 0.06 | 0.15 | 0.19 | 0.4 | 0.54 | 0.75 | 0.74 | 0.75 |
| Depreciation | 0 | 0 | 0 | 0 | 0.06 | 0.05 | 0.06 | 0.08 | 0.13 |
| PBT | 0.2 | 1.56 | 0.36 | 1.73 | 0.45 | 2.49 | 2.06 | 1.53 | 3.58 |
| Tax % | 25% | 25.64% | 25% | 42.2% | 26.67% | 28.11% | 26.7% | 28.76% | 17.88% |
| Net Profit | 0.15 | 1.15 | 0.27 | 1 | 0.33 | 1.79 | 1.5 | 1.08 | 2.94 |
| EPS (₹) | 0.15 | 0.75 | 0.18 | 0.65 | 0.21 | 1.16 | 0.97 | 0.7 | 1.91 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| Sales | 0 | 0 |
| Expenses | 0.07 | 0.04 |
| Operating Profit | -0.07 | -0.04 |
| Other Income | 0.13 | 0.01 |
| Interest | 0 | 0 |
| Depreciation | 0.5 | 0.43 |
| PBT | -0.44 | -0.46 |
| Tax % | 0% | 0% |
| Net Profit | -0.44 | -0.46 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| Equity Capital | 6.97 | 6.97 |
| Reserves | -15.84 | -16.3 |
| Borrowings | 14.6 | 14.6 |
| Other Liabilities | 0.08 | 0.08 |
| Total Liabilities | 5.81 | 5.35 |
| Fixed Assets | 3.67 | 3.24 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 2.14 | 2.11 |
| Total Assets | 5.81 | 5.35 |
Cash Flow
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Operating | 0.09 | 0.1 | -0.1 | -1.45 | 0.47 | -9.07 | 2.06 |
| Investing | 0 | 0 | -0.03 | -5.16 | -7.86 | -1.05 | -11.45 |
| Financing | -0.1 | -0.1 | 0.13 | 7.03 | 7.18 | 10.51 | 9.33 |
| Net Cash Flow | 0 | -0.01 | 0.01 | 0.42 | -0.2 | 0.39 | -0.06 |
Ratios
| Particulars | Mar 2006 | Mar 2007 |
|---|---|---|
| ROCE % | — | -8.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Omega Laboratories insights
27 extracted metrics + investor summaries across FY06–FY26.
Documents
Frequently Asked Questions about Omega Laboratories
Where is Omega Laboratories Ltd (524406) listed?
Which sector does Omega Laboratories Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524406.md for Omega Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.